KRAS and lung adenocarcinoma: SensiScreen® has a high specificity and sensitivity, is time saving, and can also be applied in other cancer types, particularly in regards to tumors in which KRAS mutational status analysis is more challenging, e.g. lung adenocarcinomas that are characterized by low numbers of cancer cells in the available cytological or histological samples.